Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage

Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage

Abstract Background To evaluate the safety and efficacy of intravitreal ziv-aflibercept (IVZ) in the management of vitreous hemorrhage (VH) in eyes with previously lasered proliferative diabetic retinopathy (PDR). Methods In a prospective multicenter study, previously lasered eyes who had dense VH f...

Full description

Bibliographic Details
Main Authors:	Ahmad M. Mansour, Mohammed Ashraf, Khalil M. El Jawhari, Michel Farah, Ahmed Souka, Chintan Sarvaiya, Sumit Randhir Singh, Alay Banker, Jay Chhablani
Format:	Article
Language:	English
Published:	BMC 2020-01-01
Series:	International Journal of Retina and Vitreous
Subjects:	Intravitreal ziv-aflibercept Panretinal photocoagulation Proliferative diabetic retinopathy Vascular endothelial growth factor Vitreous hemorrhage
Online Access:	https://doi.org/10.1186/s40942-019-0204-9

Similar Items

Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
by: Sumit Randhir Singh, et al.
Published: (2019-01-01)

Role of peripheral pan-retinal photocoagulation in diabetic macular edema treated with intravitreal ziv-aflibercept
by: Mansour AM, et al.
Published: (2019-04-01)

Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial
by: Ahmed Hosni Abd Elhamid, et al.
Published: (2020-04-01)

Retinal pigment epithelium rip following single intravitreal ziv-aflibercept injection
by: Sumit Randhir Singh, et al.
Published: (2018-01-01)

Curative effect of extra-panretinal photocoagulation on proliferative diabetic retinopathy during vitreous operation
by: Hao-Fei Zhao, et al.
Published: (2018-04-01)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
by: Paulose R, et al.
Published: (2016-09-01)

Evaluation of aflibercept and ziv-aflibercept binding affinity to vascular endothelial growth factor, stability and sterility after compounding
by: Julia de Lima Farah, et al.
Published: (2018-10-01)

Vitreous Reflux Frequency and Intraocular Pressure After First-Time Intravitreal Aflibercept Injections: Comparison of 30- and 32-Gauge Needles
by: Muto T, et al.
Published: (2020-03-01)

Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion
by: Imoro Z Braimah, et al.
Published: (2019-01-01)

Temporal Trends in the Treatment of Proliferative Diabetic Retinopathy
by: Dan Gong, MD, et al.
Published: (2021-09-01)

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects
by: Cengiz Alagöz, et al.
Published: (2016-10-01)

Ziv-aflibercept and bevacizumab for exudative age-related macular degeneration: A retrospective comparison of clinical outcomes and cost at 1 year
by: Sumit Randhir Singh, et al.
Published: (2020-01-01)

Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation on the Prevention of Macular Edema Aggravation in Proliferative Diabetic Retinopathy
by: Wungrak Choi, et al.
Published: (2020-11-01)

Efficacy of adjunctive intravitreous injection with Lucentis for neovascular glaucoma
by: Rui-Dong Gu, et al.
Published: (2014-06-01)

Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients
by: Amin E. Nawar, et al.
Published: (2020-10-01)

Sub-panretinal photocoagulation <i>vs</i> panretinal photocoagulation for pre-proliferative diabetic retinopathy: a prospective non-randomized study
by: Li Wang, et al.
Published: (2016-03-01)

Effects of intravitreal conbercept before panretinal photocoagulation on lipid exudates in diabetic macular documented by optical coherence tomography
by: Jing-Rong Shi, et al.
Published: (2020-04-01)

Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm?
by: Lihteh Wu, et al.
Published: (2019-01-01)

Intravitreal injection of Conbercept combined with trabeculectomy and panretinal photocoagulation for the treatment of neovascular glaucoma
by: Zhe Yu, et al.
Published: (2018-05-01)

Clinical effect and cost analysis of panretinal photocoagulation combined with Ranibizumab or triamcinolone acetonide for diabetic macular edema
by: Zhu-Juan Pan, et al.
Published: (2018-04-01)

Effect of intravitreal injection of Bevacizumab for vitreous hemorrhage in patients with proliferative diabetic retinopathy
by: Na Meng, et al.
Published: (2016-05-01)

Clinical research of intravitreal injection of Conbercept combined with different methods in the treatment of neovascular glaucoma
by: Li-Ping Wang, et al.
Published: (2017-02-01)

One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion
by: Mohab Eldeeb, et al.
Published: (2017-12-01)

Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab
by: Xuting Hu, et al.
Published: (2019-09-01)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
by: Fouda SM, et al.
Published: (2017-03-01)

A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer
by: John H. Strickler, et al.
Published: (2019-11-01)

Disease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC)
by: Wafik S. El-Deiry, et al.
Published: (2019-03-01)

pH of anti-VEGF agents in the human vitreous: low impact of very different formulations
by: Bianka Sobolewska, et al.
Published: (2017-06-01)

Clinical observation of Conbercept intravitreal injection combined with panretinal photocoagulation for ischemic central retinal vein occlusion
by: Yu-Rong Liu, et al.
Published: (2021-01-01)

Panretinal photocoagulation versus intravitreal injection of bevacizumab as a preoperative adjuvant before vitrectomy in the management of proliferative diabetic retinopathy
by: Mohammed S Ahmed
Published: (2019-01-01)

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
by: Jia-Kang Wang, et al.
Published: (2018-09-01)

Study on Difrarel protecting dark adaptation function in the patients with diabetic retinopathy
by: Ying Hui, et al.
Published: (2017-03-01)

Long term effect of panretinal photocoagulation on retinal nerve fiber layer parameters in patients with proliferative diabetic retinopathy
by: Meenakshi Wadhwani, et al.
Published: (2019-01-01)

Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma
by: Jin-Tao Sun, et al.
Published: (2017-03-01)

Pattern scan laser versus single spot laser in panretinal photocoagulation treatment for proliferative diabetic retinopathy
by: Shu Zhang, et al.
Published: (2017-02-01)

Clinical observation on treatment of diabetic retinopathy with laser photocoagulation in the primary hospital
by: Te-Hong Zhou, et al.
Published: (2014-04-01)

Subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study
by: Jhingan M, et al.
Published: (2018-01-01)

Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study
by: Chen YX, et al.
Published: (2020-03-01)

PLASMA LEVELS OF ANGIOGENIC AND ANGIOSTATIC FACTORS AFTER PANRETINAL PHOTOCOAGULATION FOR PROLIFERATIVE DIABETIC RETINOPATHY
by: Bhaskar Gaonkar
Published: (2020-09-01)

Clinical research on laser therapy and Ranibizumab for proliferative diabetic retinopathy
by: Hong Zou, et al.
Published: (2016-01-01)